本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aura Biosciences, Inc.

7.06
-0.0300-0.42%
盘后7.060.00000.00%17:17 EDT
成交量:28.57万
成交额:199.61万
市值:4.53亿
市盈率:-4.01
高:7.07
开:7.02
低:6.86
收:7.09
52周最高:7.48
52周最低:4.35
股本:6,415.05万
流通股本:3,666.37万
量比:0.95
换手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-1.7599
每股收益(LYR):-1.7599
净资产收益率:-73.52%
总资产收益率:-40.06%
市净率:3.31
市盈率(LYR):-4.01

数据加载中...

2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/23

重要事件披露

8-K - Current report
2022/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

重要事件披露

8-K - Current report
2021/11/24

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/10/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933